This investment will be used to augment Chemizon Beijing’s integrated discovery platform by adding capabilities in the area of biology and computational chemistry.
Anthony Piscopio, president, CEO and chairman of Optomagic, said: “We are seeing a significant increase in interest from our partners to move towards value-added discovery collaborations in Asia.
“This additional investment will strengthen our discovery platform both by the addition of key hires to our management team and by expanding our capabilities in the area of discovery research.”